Search by Drug Name or NDC

    NDC 67877-0416-90 Valsartan 80 mg/1 Details

    Valsartan 80 mg/1

    Valsartan is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is VALSARTAN.

    Product Information

    NDC 67877-0416
    Product ID 67877-416_205dbc75-b804-4b40-85ee-3c2d9de93de0
    Associated GPIs 36150080000320
    GCN Sequence Number 048401
    GCN Sequence Number Description valsartan TABLET 80 MG ORAL
    HIC3 A4F
    HIC3 Description ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST
    GCN 13846
    HICL Sequence Number 012204
    HICL Sequence Number Description VALSARTAN
    Brand/Generic Generic
    Proprietary Name Valsartan
    Proprietary Name Suffix n/a
    Non-Proprietary Name Valsartan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 80
    Active Ingredient Units mg/1
    Substance Name VALSARTAN
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205536
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0416-90 (67877041690)

    NDC Package Code 67877-416-90
    Billing NDC 67877041690
    Package 90 TABLET, FILM COATED in 1 BOTTLE (67877-416-90)
    Marketing Start Date 2019-03-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.20282
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description VALSARTAN 80 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 7b4ecaf9-e84c-4660-9cd1-65a238efd8a8 Details

    Revised: 1/2022